StockData
Enliven Therapeutics, Inc. logo

Enliven Therapeutics, Inc. (ELVN) stock

ELVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$44.89−1.96 (-4.18%)

Close on Nov 18, 2026Market cap $3.29BP/E –Yield –

Enliven Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Enliven Therapeutics

Enliven Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Enliven Therapeutics figures

See a number that looks wrong?